Recommendations for Management of Clinically Significant Drug-Drug Interactions with Statins and Select Agents Used in Patients with Cardiovascular Disease: A Scientific Statement from the American Heart Association

Barbara S. Wiggins; Joseph J. Saseen; Robert L. Page; Brent N. Reed; Kevin Sneed; John B. Kostis; David Lanfear; Salim Virani; Pamela B. Morris

doi:10.1161/CIR.0000000000000456

Recommendations for Management of Clinically Significant Drug-Drug Interactions with Statins and Select Agents Used in Patients with Cardiovascular Disease: A Scientific Statement from the American Heart Association

Barbara S. Wiggins
, Joseph J. Saseen
, Robert L. Page
, Brent N. Reed
, Kevin Sneed
, John B. Kostis
, David Lanfear
, Salim Virani
, Pamela B. Morris

Office of the Provost

Research output: Contribution to journal › Article › peer-review

307 Citations (Scopus)

Original language	English (US)
Pages (from-to)	e468-e495
Journal	Circulation
Volume	134
Issue number	21
DOIs	https://doi.org/10.1161/CIR.0000000000000456
Publication status	Published - 22 Nov 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

AHA Scientific Statements
anti-arrhythmic agents
anticoagulants
calcium channel blockers
cardiovascular disease
drug-related side effects and adverse reactions
fenofibrate/fenofibric acid derivatives
gemfibrozil
hydroxymethylglutaryl-CoA reductase inhibitors
immunosuppressive agents

Access to Document

10.1161/CIR.0000000000000456

Cite this

Wiggins, B. S., Saseen, J. J., Page, R. L., Reed, B. N., Sneed, K., Kostis, J. B., Lanfear, D., Virani, S., & Morris, P. B. (2016). Recommendations for Management of Clinically Significant Drug-Drug Interactions with Statins and Select Agents Used in Patients with Cardiovascular Disease: A Scientific Statement from the American Heart Association. Circulation, 134(21), e468-e495. https://doi.org/10.1161/CIR.0000000000000456

@article{e0061eded86b4337aee16cb0cef51c63,

title = "Recommendations for Management of Clinically Significant Drug-Drug Interactions with Statins and Select Agents Used in Patients with Cardiovascular Disease: A Scientific Statement from the American Heart Association",

keywords = "AHA Scientific Statements, anti-arrhythmic agents, anticoagulants, calcium channel blockers, cardiovascular disease, drug-related side effects and adverse reactions, fenofibrate/fenofibric acid derivatives, gemfibrozil, hydroxymethylglutaryl-CoA reductase inhibitors, immunosuppressive agents",

author = "Wiggins, \{Barbara S.\} and Saseen, \{Joseph J.\} and Page, \{Robert L.\} and Reed, \{Brent N.\} and Kevin Sneed and Kostis, \{John B.\} and David Lanfear and Salim Virani and Morris, \{Pamela B.\}",

year = "2016",

month = nov,

day = "22",

doi = "10.1161/CIR.0000000000000456",

language = "English (US)",

volume = "134",

pages = "e468--e495",

journal = "Circulation",

issn = "0009-7322",

publisher = "Lippincott Williams and Wilkins",

number = "21",

}

Wiggins, BS, Saseen, JJ, Page, RL, Reed, BN, Sneed, K, Kostis, JB, Lanfear, D, Virani, S & Morris, PB 2016, 'Recommendations for Management of Clinically Significant Drug-Drug Interactions with Statins and Select Agents Used in Patients with Cardiovascular Disease: A Scientific Statement from the American Heart Association', Circulation, vol. 134, no. 21, pp. e468-e495. https://doi.org/10.1161/CIR.0000000000000456

Recommendations for Management of Clinically Significant Drug-Drug Interactions with Statins and Select Agents Used in Patients with Cardiovascular Disease: A Scientific Statement from the American Heart Association. / Wiggins, Barbara S.; Saseen, Joseph J.; Page, Robert L. et al.
In: Circulation, Vol. 134, No. 21, 22.11.2016, p. e468-e495.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Recommendations for Management of Clinically Significant Drug-Drug Interactions with Statins and Select Agents Used in Patients with Cardiovascular Disease

T2 - A Scientific Statement from the American Heart Association

AU - Wiggins, Barbara S.

AU - Saseen, Joseph J.

AU - Page, Robert L.

AU - Reed, Brent N.

AU - Sneed, Kevin

AU - Kostis, John B.

AU - Lanfear, David

AU - Virani, Salim

AU - Morris, Pamela B.

PY - 2016/11/22

Y1 - 2016/11/22

KW - AHA Scientific Statements

KW - anti-arrhythmic agents

KW - anticoagulants

KW - calcium channel blockers

KW - cardiovascular disease

KW - drug-related side effects and adverse reactions

KW - fenofibrate/fenofibric acid derivatives

KW - gemfibrozil

KW - hydroxymethylglutaryl-CoA reductase inhibitors

KW - immunosuppressive agents

UR - https://www.scopus.com/pages/publications/84991502977

U2 - 10.1161/CIR.0000000000000456

DO - 10.1161/CIR.0000000000000456

M3 - Article

C2 - 27754879

AN - SCOPUS:84991502977

SN - 0009-7322

VL - 134

SP - e468-e495

JO - Circulation

JF - Circulation

IS - 21

ER -

Recommendations for Management of Clinically Significant Drug-Drug Interactions with Statins and Select Agents Used in Patients with Cardiovascular Disease: A Scientific Statement from the American Heart Association

UN SDGs

Keywords

Access to Document

Other files and links

Cite this